N-[(Z)-4-methoxy-3-methyl-but-2-enyl]-N,9-dimethyl-purin-6-amine
|
|
Descriptors Computed from Structure
Canonical SMILES:
CC(=CCN(C)C1=NC=NC2=C1N=CN2C)COC
Isomeric SMILES
C/C(=C/CN(C)C1=NC=NC2=C1N=CN2C)/COC
InChI
InChI=1S/C13H19N5O/c1-10(7-19-4)5-6-17(2)12-11-13(15-8-14-12)18(3)9-16-11/h5,8-9H,6-7H2,1-4H3/b10-5-
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 9-[(2S,5S)-3,4-dimethoxy-5-(methoxymethyl)oxolan-2-yl]-N-[(Z)-4-methoxy-3-methyl-but-2-enyl]-N-methyl-purin-6-amine
- (8Z,11Z)-heptadeca-8,11-dienal
- 2-butan-2-yl-3-methyl-pyrazine
- (E)-4-(2,3,6,6-tetramethylcyclohex-2-en-1-yl)but-3-en-2-one
- methyl 3-[(3R,5S,7R,12S)-10,13-dimethyl-3,7,12-tris(trimethylsilyloxy)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butanoate
- methyl 3-[(3R,5S,7S)-10,13-dimethyl-3,7-bis(trimethylsilyloxy)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butanoate
- [(3R,5S,7R,12S)-10,13-dimethyl-3,7-bis(trimethylsilyloxy)-17-(4-trimethylsilyloxybutan-2-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl]oxy-trimethyl-silane
- 3-[(3R,5S,7R)-10,13-dimethyl-3,7-bis(trimethylsilyloxy)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butoxy-trimethyl-silane
- [(3R,5S,7R,12S)-10,13-dimethyl-17-(5-methyl-6-trimethylsilyloxy-hexan-2-yl)-3,7-bis(trimethylsilyloxy)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl]oxy-trimethyl-silane
- [5-[(3R,5S,7R)-10,13-dimethyl-3,7-bis(trimethylsilyloxy)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-hexoxy]-trimethyl-silane
